There have been no previous reports in the anaesthetic literature regarding the airway management during anaesthesia of patients with a lipid storage disease. In a 40-year period at a busy paediatric hospital 15 patients with a lipid storage disease were anaesthetised on 19 occasions. Eight patients were intubated, three of them twice. No difficulties in airway management during anaesthesia were documented.
The lipid storage diseases are a group of rare familial disorders characterised by the abnormal deposition of lipids in body tissues (incidence 1 in 70,000 to 1 in 100,000 live births). Confronted recently with the prospect of anaesthetising a two-year-old child with Gaucher's disease for a splenectomy we pondered whether patients with a lipid storage disease presented the same airway problem during anaesthesia as do patients with a mucopolysaccharidosis.
The purpose of this retrospective study was to investigate the airway management during anaesthesia of patients with a lipid storage disease.
METHOD The case history notes of all patients with a lipid storage disease admitted to the Royal Alexandra Hospital for Children, Sydney, during the forty years 1942 to 1982, were reviewed. The subclassification of the lipid storage disease was recorded together with details of any surgery performed. From scrutllllSlng the anaesthetic record chart the airway management during anaesthesia was determined and any difficulty with the airway was noted.
RESULTS From 1942 to 1982, 30 patients with a lipid storage disease were treated at the hospital. Nineteen operations, all under general anaesthesia, were performed in fifteen patients. The average age of patients having surgery performed was 4 years and 3 months, with an age range from 1 month to 13 years. The range of surgery performed in these patients is shown in Table 1 .
Five patients were intubated once and three patients were intubated twice. No difficulty was reported in visualising the larynx in these eight patients. Seven patients were anaesthetised with a face mask and no difficulty was recorded in maintaining a patent airway. Sachs disease), although over ten different forms of lipid storage disease are recognised. The basic genetic abnormality involves lysosomal enzymes which catabolise naturally occurring complex lipids.! Lipid accumulates primarily in the cells of the reticuloendothelial system but the brain, heart, lungs and larynx are sometimes involved. Inheritance is autosomal recessive and these disorders occur with an unusually high frequency among Ashkenazi Jews (1 in 2,500 live births).
Three clinical presentations of the lipid storage diseases are recognised. The first type is an acute neuropathic form which is usually apparent before six months of age and fatal in early childhood. The second type is a nonneuropathic form which may be manifest at any time from birth to old age. Major signs are hepatosplenomegaly, haematological abnormalities attributable to hyperplenism and bone lesions. The third type is a chronic neuropathic form in which the visceral organs and central nervous system are involved but the signs of neurological damage appear later than in early childhood.
Smith 2 is of the opinion that the greatest difficulty in anaesthetising these patients is associated with upper airway obstruction due to lymphoid hyperplasia. A contrary view is held by Katz 3 who maintains that the difficulty of the anaesthetic management of these patients is more related to the surgical procedure than to the metabolic-enzymatic difficulties.
Our retrospective study reviewed the airway management during anaesthesia of 15 patients with a lipid storage disease. No difficulty in airway management was recorded and no patient required urgent tracheostomy or endotracheal intubation. It is possible that minor difficulties experienced with a patient's airway during anaesthesia were not documented in the patient's anaesthetic record chart.
